Donor Qualification
At Cryobank America, we are committed to providing the highest quality of sperm so you can build your happy, healthy family.
Rigorous Screening
Our donors undergo a rigorous background, personality, and behavioral screening by our staff physician and psychiatrist so that we can provide you with the best options to build your family.
Industry Exceeding Testing For Donor Qualification
All donors are subject to an extensive medical questionnaire and advanced genetic and infectious disease testing as required by the FDA, which, in most cases, exceeds the established standard. We continually endeavor to be the NEW Standard (in) Fertility.
Please contact us for more information on our donor qualification, screening, and testing.
Contact UsPlease contact us for more information on our donor qualification, screening, and testing.
Quality Sperm
At Cryobank America, we strive to maintain the industry’s highest standards for donor screening, testing, semen processing, and storage to provide quality, motile sperm. Our operations are fully licensed and inspected to ensure the best opportunity for a trustworthy and positive pregnancy in the future.
Each donor is identified through a biometric identification device and is compared to facial photographs, which are stored on-site to ensure proper proof of identity.
In addition to these quality assurance practices, Cryobank America leads the industry in providing the highest sperm counts per vial, increasing your chances of successful conception.
As a part of our commitment to helping you build your happy, healthy family, we offer the Conception Commitment™ program.
Our Conception Commitment™Each donor is identified through a biometric identification device and is compared to facial photographs, which are stored on-site to ensure proper proof of identity.
In addition to these quality assurance practices, Cryobank America leads the industry in providing the highest sperm counts per vial, increasing your chances of successful conception.
As a part of our commitment to helping you build your happy, healthy family, we offer the Conception Commitment™ program.
Donor Screening
Infectious Disease Testing
Each donor must also complete an accompanying Medical Social Questionnaire (MSQ) with each Infectious Disease Testing (IDT). The IDT covers the following tests:
- Chlamydia trachomatis (C. trachomatis)
- Cytomegalovirus Antibodies (Total Antibody)
- Cytomegalovirus Antibodies (IgM fraction)
- HBV
- Hepatitis B Surface Antigen (HBsAg)
- Hepatitis B Core Antibody (HBcAb; HBc IgG-IgM)
- Hepatitis C Virus Antibody (HCV)
- HIV-1 / HCV / H / HBV NAT
- Human Immunodeficiency Virus 1, O, and 2 (HIV 1/O/2)
- Human T-Cell Lymphotropic Virus-I / II (HTLV-I / II)
- Neisseria gonorrhea (N. gonorrhea)
- Syphilis serology (Treponema pallidum)
- West Nile Virus NAT
Non-Infectious Disease Testing
Non-infectious analyses are also performed on all Cryobank America Donors. The types of analyses in the blood chemistry profile include:
- Albumin
- Alkaline Phosphatase
- Alanine Aminotransferase (ALT)
- Aspartate Aminotransferase (AST)
- Calcium
- Cholesterol (HDL, LDL, VLDL)
- Creatinine
- Glucose
- Lactate Dehydrogenase (LDH)
- Iron (Total Fe, Fe Binding, % Saturation)
- Triglycerides
- Total Bilirubin
- Total Protein
- Urea Nitrogen
- Uric Acid
Complete Blood Count
The following parameters are evaluated in the Completed Blood Count:
- Cell morphology
- Hematocrit
- Hemoglobin
- Mean Corpuscular Hemoglobin (MCH)
- Mean Corpuscular Hemoglobin Concentration (MCHC)
- Mean Corpuscular Volume (MCV)
- Mean Platelet Volume (MPV)
- Microscopic examination of Basos
- Eos
- Lymphs
- Polys
- Red Blood
- Platelet Screen
- Red Blood Cell (RBC) Count
- White Blood Cell (WBC) Count
Urinalysis
CA Donors will also undergo routine urinalyses, which is used to screen for the general health of a donor’s urinary tract system.
The following parameters are evaluated with the urinalysis:
- Bilirubin
- Clarity
- Color
- Glucose
- Ketones
- Leukocyte esterase
- pH
- Protein
- Microscopic evaluation for squamous cells
- Casts
- Crystals
Drug Testing and Criminal History Background Check
Drug use has been known to affect the potency of motile sperm. Therefore, in addition to the testing performed above, Cryobank America performs criminal background checks and drug testing on all donors to provide the highest quality products to our clients.
Psychiatric Evaluation (a Cryobank America Exclusive!)
As part of joining the Cryobank America Sperm Donor Program, each donor must visit a psychiatrist and undergo a complete mental health evaluation and counseling.
Chromosome Analysis
Chromosome Analysis (also known as Karyotyping) is used to detect chromosome abnormalities, which can help uncover hidden genetic diseases, birth defects, blood disorders, and lymphatic system disorders. All Cryobank America donors undergo Chromosome Analysis testing.
Myriad Women's Health
Genetic Screening
Every Cryobank America donor will have genetic carrier screening performed by Myriad Women's Health, a CLIA-regulated testing facility. Genetic diseases that Cryobank America Donors are screened for include:
A
- 11-beta-hydroxylase-deficient Congenital Adrenal Hyperplasia
- 6-pyruvoyl-tetrahydropterin synthase deficiency
- ABCC8-related familial hyperinsulinism
- adenosine deaminase deficiency
- alpha thalassemia, HBA1/HBA2-related
- alpha-mannosidosis
- alpha-sarcoglycanopathy
- Alstrom syndrome
- AMT-related glycine encephalopathy
- Andermann syndrome
- argininemia
- argininosuccinic aciduria
- aspartylglucosaminuria
- ataxia with vitamin E deficiency
- ataxia-telangiectasia
- ATP7A-related disorders
- autoimmune polyglandular syndrome type 1
- autosomal recessive osteopetrosis type 1
- autosomal recessive polycystic kidney disease, PKHD1-related
- autosomal recessive spastic ataxia of Charlevoix-Saguenay
B
C
- calpainopathy
- Canavan disease
- carbamoylphosphate synthetase I deficiency
- carnitine palmitoyltransferase IA deficiency
- carnitine palmitoyltransferase II deficiency
- cartilage-hair hypoplasia
- cerebrotendinous xanthomatosis
- citrullinemia type 1
- CLN3-related neuronal ceroid lipofuscinosis
- CLN5-related neuronal ceroid lipofuscinosis
- CLN6-related neuronal ceroid lipofuscinosis
- CLN8-related neuronal ceroid lipofuscinosis
- Cohen syndrome
- COL4A3-related Alport syndrome
- COL4A4-related Alport syndrome
- combined pituitary hormone deficiency, PROP1-related
- congenital adrenal hyperplasia, CYP21A2-related
- congenital disorder of glycosylation type Ia
- congenital disorder of glycosylation type Ic
- congenital disorder of glycosylation, MPI-related
- Costeff optic atrophy syndrome
- cystic fibrosis
- cystinosis
D-F
- D-bifunctional protein deficiency
- delta-sarcoglycanopathy
- dihydrolipoamide dehydrogenase deficiency
- dysferlinopathy
- dystrophinopathy (including Duchenne/Becker muscular dystrophy)
- ERCC6-related disorders
- ERCC8-related disorders
- EVC-related Ellis-van Creveld syndrome
- EVC2-related Ellis-van Creveld syndrome
- Fabry disease
- familial dysautonomia
- familial Mediterranean fever
- Fanconi anemia complementation group A
- Fanconi anemia, FANCC-related
- FKRP-related disorders
- FKTN-related disorders
- fragile X syndrome
- free sialic acid storage disorders
G-H
- galactokinase deficiency
- galactosemia
- gamma-sarcoglycanopathy
- Gaucher disease
- GJB2-related DFNB1 nonsyndromic hearing loss and deafness
- GLB1-related disorders
- GLDC-related glycine encephalopathy
- glutaric acidemia, GCDH-related
- glycogen storage disease type Ia
- glycogen storage disease type Ib
- glycogen storage disease type III
- GNE myopathy
- GNPTAB-related disorders
- HADHA-related disorders
- Hb beta chain-related hemoglobinopathy
- hereditary fructose intolerance
- Herlitz junctional epidermolysis bullosa, LAMB3-related
- hexosaminidase A deficiency
- HMG-CoA lyase deficiency
- holocarboxylase synthetase deficiency
- homocystinuria, CBS-related
- hydrolethalus syndrome
- hypophosphatasia
I-L
- isovaleric acidemia
- Joubert syndrome 2
- junctional epidermolysis bullosa, LAMA3-related
- junctional epidermolysis bullosa, LAMC2-related
- KCNJ11-related familial hyperinsulinism
- Krabbe disease
- LAMA2-related muscular dystrophy
- Leigh syndrome, French-Canadian type
- lipoid congenital adrenal hyperplasia
- lysosomal acid lipase deficiency
M
- maple syrup urine disease type Ia
- maple syrup urine disease type Ib
- maple syrup urine disease type II
- medium chain acyl-CoA dehydrogenase deficiency
- megalencephalic leukoencephalopathy with subcortical cysts
- metachromatic leukodystrophy
- methylmalonic acidemia, cblA type
- methylmalonic acidemia, cblB type
- methylmalonic aciduria and homocystinuria, cblC type
- MKS1-related disorders
- mucolipidosis III gamma
- mucolipidosis IV
- mucopolysaccharidosis type I
- mucopolysaccharidosis type II
- mucopolysaccharidosis type IIIA
- mucopolysaccharidosis type IIIB
- mucopolysaccharidosis type IIIC
- MUT-related methylmalonic acidemia
- MYO7A-related disorders
N-O
P-R
- PCCA-related propionic acidemia
- PCCB-related propionic acidemia
- PCDH15-related disorders
- Pendred syndrome
- peroxisome biogenesis disorder type 1
- peroxisome biogenesis disorder type 3
- peroxisome biogenesis disorder type 4
- peroxisome biogenesis disorder type 5
- peroxisome biogenesis disorder type 6
- phenylalanine hydroxylase deficiency
- POMGNT-related disorders
- Pompe disease
- PPT1-related neuronal ceroid lipofuscinosis
- primary carnitine deficiency
- primary hyperoxaluria type 1
- primary hyperoxaluria type 2
- primary hyperoxaluria type 3
- pycnodysostosis
- pyruvate carboxylase deficiency
- rhizomelic chondrodysplasia punctata type 1
- RTEL1-related disorders
S-U
- Sandhoff disease
- short-chain acyl-CoA dehydrogenase deficiency
- Sjogren-Larsson syndrome
- SLC26A2-related disorders
- Smith-Lemli-Opitz syndrome
- spastic paraplegia type 15
- spinal muscular atrophy
- spondylothoracic dysostosis
- TGM1-related autosomal recessive congenital ichthyosis
- TPP1-related neuronal ceroid lipofuscinosis
- tyrosine hydroxylase deficiency
- tyrosinemia type I
- tyrosinemia type II
- USH1C-related disorders
- USH2A-related disorders
- usher syndrome type 3
V-X
- very-long-chain acyl-CoA dehydrogenase deficiency
- Wilson disease
- X-linked adrenoleukodystrophy
- X-linked Alport syndrome
- X-linked congenital adrenal hypoplasia
- X-linked juvenile retinoschisis
- X-linked myotubular myopathy
- X-linked severe combined immunodeficiency
- xeroderma pigmentosum group A
- xeroderma pigmentosum group C
Happy, Healthy, Families begin here...